Navigation Links
Grant supports LSUHSC research on how like cell receptor systems determine very different functions
Date:7/24/2009

New Orleans, LA Andy Catling, PhD, Associate Professor in the Department of Pharmacology and the Stanley S. Scott Cancer Center at LSU Health Sciences Center New Orleans, has been awarded a $177, 500 supplement to his RO1 grant by the National Institute of General Medical Sciences to support his research on the mechanism by which seemingly similar cell receptor systems determine quite different functions influenced by hormones and drugs.

"We are interested in how the generic ERK signaling pathway confers specific physiological outcomes such as proliferation, differentiation and cell migration," notes Dr. Catling. "We hypothesize that specificity is conferred by the action of input- and output-specific 'scaffolding' molecules that assemble the pathway around growth factor receptors."

The supplement was funded through the American Recovery and Reinvestment Act and will be used to help retain key personnel needed to identify and characterize ERK phosphorylation targets proteins to which phosphate groups can be added, increasing or decreasing protein function specified by the scaffold. These phosphorylation targets are involved in the development of disease.

Dr. Ashok Pullikuth in Catling's lab has recently identified a protein that functions in the intracellular movement and cell division activity of growth factor receptors as a novel phosphorylation target. Understanding this novel mechanism might be important in treating conditions that are dependent upon specific growth factor receptors, like some breast cancers in which the EGF receptor family drives growth and survival.

"Our studies might provide insight into how specific functions of a pathway might be targeted therapeutically while not eliminating all essential housekeeping functions of the pathway," Dr. Catling says. "The beauty of research is that no one knows just how useful their findings will be in the future there may be entirely unexpected benefits in addition to more predictable outcomes."

These key personnel and the data they generate are essential to submit a competitive renewal of this RO1 grant in November.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related biology news :

1. UC San Diegos $3 million NSF grant to fund science festivals
2. EPA grant to University of Chicago for research on food allergy triggers
3. $2 million grant aids study of lung cancer in people who never smoked
4. $20 million NIH grant to transform clinical research at UIC
5. $29.4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation
6. LSUHSCs Bazan awarded ARRA grant to preserve vision
7. Show me the money! MDA greenlights grants
8. T-STAR grant funds genetic studies on shrimp and papaya and endangered cycad rescue
9. NYU Langone Medical Center awarded NIH grants totaling $1,560,000
10. UTSA wins San Antonio Area Foundation grant to further chlamydia research
11. UC Davis grant zeroes in on novel asthma diagnosis and treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
Breaking Biology News(10 mins):
(Date:2/3/2016)... DIEGO , Feb. 3, 2016   ... company with the first pluripotent stem cell-derived islet ... diabetes in clinical-stage development, today announced that ViaCyte ... Pharmaceutical Companies of Johnson & Johnson, have agreed ... group into ViaCyte.  The agreement provides ViaCyte with ...
(Date:2/3/2016)... , Feb. 3, 2016 Ascendis Pharma ... company that applies its innovative TransCon technology to address ... at an upcoming investor conference.Event:2016 Leerink Partners Global Healthcare ... Date:  , Wednesday, February 10, 2016 Time:  , ... www.ascendispharma.com . --> An audio webcast of ...
(Date:2/3/2016)... Colorado (PRWEB) , ... February 03, 2016 , ... ... hospitals, has established a new office dedicated to the North American healthcare market. ... turnkey solutions to healthcare facilities. The company will provide new pneumatic tube ...
(Date:2/3/2016)... ... February 03, 2016 , ... Resilinc ... summarizes and analyzes nearly 750 unique supply chain notifications and alerts generated by ... , Supply chain risk management practitioners subscribe to the EventWatch service to receive ...
Breaking Biology Technology: